Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.

In order to support the Philippine Medicines Policy and its goal in ensuring sustainable access to essential medicines by 2030, the Department of Health issued Administrative Order No. 2022-0025 dated 30 June 2022 to serve as the overall strategic direction and framework to all stakeholders for the imlementation of the PMP.